COREE Pohang Temporarily Granted Approval for DX24 under the Regulatory Sandbox


Coree Pohang, a digital healthcare provider, has announced that its untact medical service for overseas Koreans, DX24, has been granted temporary permission in the field of untact medical services for overseas Koreans by the 1st Industry Convergence Regulatory Special Deliberation Committee this year. On the 25th, Coree Pohang received the original copy of the temporary permit from the Ministry of Trade, Industry, and Energy.

DX24 is an online platform that links overseas residents with domestic medical institutions through audio and video calls to provide remote medical services and prescription issuance services. It also provides local medical information, including hospital and general medicines, based on the medical checkup.

Coree Pohang signed a service agreement with Myongji Medical Foundation last November. Starting with pediatrics, internal medicine, and endocrinology, for which the company has secured professional medical staff through cooperation with Myongji Medical Foundation, the company plans to serve overseas patients. It also plans to develop a differentiated and tailored untact medical service by connecting with Coree's infrastructures worldwide, including the United States, Italy, and China.

Yoo Geon-sang, CEO of Coree Pohang, said, "We will lay the foundation to develop untact medical treatment services and medical services that allow overseas patients to access Korea's advanced medical services through this temporary permission."

In the meantime, Coree is reinforcing its position as a digital healthcare company by serving the How to Care App for wound care and developing a pregnancy healthcare app. Last year, it signed a contract for a site of about 50,000 square meters in the Pohang Convergence Technology Industrial Zone and has been forming the KHUB Science Park as a research and production hub for pharmaceuticals and diagnostic medical devices, such as vaccines and immune-anticancer.

Source: Seoul Shinmun